openPR Logo
Press release

Human Coagulation Factor VII Market Size, Status and Forecast 2025

06-19-2017 11:19 PM CET | Health & Medicine

Press release from: Transparency Market Research

Human Coagulation Factor VII Market Size, Status and Forecast

Human coagulation factor VII is a single chain plasma glycoprotein that initiates the process of blood clotting in the coagulation cascade. It belongs to the enzymeserine protease family. Factor VII is produced in the liver and then circulated in the plasma where it comes in contact with the tissue factor, an integral membrane protein. After binding, factor VII is converted into factor VIIa which further initiates the coagulation pathway. A factor VII deficiency (a disorder wherein the body is not able to produce factor VII) leads to a condition where blood is unable to clot, causing excessive and prolonged bleeding after a surgery or injury. This deficiency is either acquired or inherited – the former after birth, which may be a result of the effect of medication or diseases which interfere with the production of factor VII such as liver diseases and vitamin K deficiency. Major symptoms associated with factor VII deficiency are longer duration of bleeding caused by wounds, bleeding joints, bleeding gums, and heavy menstrual periods. Diagnosis is mostly accomplished through lab tests such as factor assay, inhibitor tests, and prothrombin time (PT) to measure the functioning of factors I, II, V, VII, and X.

Get accurate market forecast and analysis on the Human Coagulation Factor VII Market. Request a sample to stay abreast on the key trends impacting this market.

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=24074

Hemophilia is an inherited medical condition in which the patient’s blood is unable to clot. The symptoms could be mild to severe. In severe cases, patients experience internal bleeding. Treatment of hemophilia is usually in the form of medication for genetically engineered factor VII to prevent and treat prolonged bleeding. The rising incidence of hemophilia is a major driver of the human coagulation factor VII market, apart from initiatives taken by governments to create awareness regarding its prevention and treatment and the advent of new techniques for the development of safer and cost-effective products. Limited awareness in the medical profession and among policy makers about the medical conditions in which human coagulation factors VII can be used is a major restraining factor for this market.

The global human coagulation factor VII market has been categorized based on product type into the following categories: recombinant factor VII and plasma-derived factor VII. The former is anticipated to dominate the market due to the safety and efficiency associated with the use of the recombinant product as compared to plasma-derived factor VII. However, improvements in viral inactivation and advanced screening method have greatly improved the safety aspect of plasma-derived factor VII. In terms of application, the global human coagulation factor VII market has been segmented into the following sections: hemophilia, surgery, and others. Hemophilia is predicted to lead the market, followed by surgery. By end-user, the market has been divided into the following groups: hospitals, ambulatory surgery centers, specialty clinics, and others.

View Report @ http://www.transparencymarketresearch.com/human-coagulation-factor-vii-market.html

Geographically, the global human coagulation factor VII market is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is a major market, followed by Europe. The rising number of hemophilia patients, surge in health care expenditure, and increasing awareness about hemophilia created by government organizations in developed countries are factors contributing to the expansion of the market in this region. The hemophilia population in developing countries accounts for about 80% of the global hemophilia population and is projected to emerge as a lucrative market owing to the increasing efforts taken by government organizations to create awareness and the involvement of NGOs to create better health care facilities and educate patients regarding available treatment.

Key players in the global market include Baxter International Inc, Bayer AG, Pfizer Inc., CSL Behring, Grifols USA, LLC, Novo Nordisk, Octapharma AG, ProSpec- Tany Technogene Ltd., Enzyme Research Laboratories, and others.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Human Coagulation Factor VII Market Size, Status and Forecast 2025 here

News-ID: 586171 • Views: 329

More Releases from Transparency Market Research

Ambient Food Packaging Market to Register Substantial Expansion in Next 5 Years …
Ambient food packaging refers to packing a food product in pasteurised and sterilized packs to increase its shelf life. Ambient food packing has become a trend in the food packaging industry and ambient food products are preferred by majority of the consumers over others. Increasing demand for having more empty space in chill cabinets calls for the adoption of the food packaging methods that can offer a better shelf life
Horizontal Fan Coil Market is set to Garner Staggering Revenues by 2027 - TMR
Global Fan Coil Unit Market: Overview According to a new market report pertaining to the global fan coil unit market published by Transparency Market Research the global fan coil unit market is anticipated to reach volume of 11,378.2 thousand units by 2027. The fan coil unit market is projected to expand at a CAGR of 3.6 % from 2019 to 2027 in terms of sale. Growth of the fan coil unit
RTC IC Market – Opportunities in Key Application Sectors by 2029
Global Real-time Clock (RTC) IC Market: Introduction Transparency Market Research delivers key insights on the global real-time clock (RTC) IC market. In terms of revenue, the global real-time clock IC market is estimated to expand at a CAGR of ~4% during the forecast period, owing to numerous factors, regarding which, TMR offers thorough insights and forecasts in its report on the global real-time clock IC market. A real-time clock IC is a
Healthcare Packaging Market: Explore Top Factors that Will Boost the Global Mark …
Healthcare Packaging Market: Introduction The latest report published by Transparency Market Research on the global healthcare packaging market, includes global industry analysis, share, size, growth trends and forecast for 2021-2029. The current value of the global healthcare packaging market is US$ 100 Bn and is anticipated to expand to US$ 155 Bn by the year 2029. Growth of the pharmaceutical industry and high demand for medicinal supplies & drugs have created

All 5 Releases


More Releases for VII

Human Coagulation Factor VII Market 2020 Demand Analysis – NovoNordisk
Global Human Coagulation Factor VII Market Growth 2020-2025 The report will make detailed analysis mainly on in-depth research on the development environment, Market size, development trend, operation situation and future development trend of Human Coagulation Factor VII Market on the basis of stating current situation of the industry in 2020. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect
Global Human Coagulation Factor VII Sales Market Report 2018| Baxter, Bayer, Pfi …
Albany, NY, 24th July : Recent research and the current scenario as well as future market potential of "Global Human Coagulation Factor VII Sales Market Report 2018" globally. This report studies the global Human Coagulation Factor VII market status and forecast, categorizes the global Human Coagulation Factor VII market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe,
Global Human Coagulation Factor VII Market 2018 - NovoNordisk
Eminent Market, recently published a detailed market research study focused on the "Human Coagulation Factor VII Market" across the global, regional and country level. The report provides 360° analysis of "Human Coagulation Factor VII Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Human Coagulation Factor VII industry, and estimates the future
Human Coagulation Factor VII Market Size to Grow Exponentially during 2017 - 202 …
Human coagulation factor VII is a single chain plasma glycoprotein that initiates the process of blood clotting in the coagulation cascade. It belongs to the enzyme serine protease family. Factor VII is produced in the liver and then circulated in the plasma where it comes in contact with the tissue factor, an integral membrane protein. After binding, factor VII is converted into factor VIIa which further initiates the coagulation pathway.
Human Coagulation Factor VII Market 2017 : Startup Strategy Resources, Grow Pric …
The recent report of Market Research Store on the “Human Coagulation Factor VII Market Research” has the complete assessment of the latest trends of the global Human Coagulation Factor VII market. The report focuses on the manufacturing challenges that are being faced and provides the solutions and the strategies that have been implemented to overcome the problems. Deep researches and analysis were done during the preparation of the report. The information
EMG Executive to Speak at CASE District VII Conference
IRVINE, CA – Earthbound Media Group (EMG) announces an upcoming speaking engagement featuring Chief Visionary Officer and Managing Partner Damien Navarro at a track session for the 2008 “Shaping the Future: The New Dimensions of Advancement” CASE District VII Conference. Presenting alongside University of Nevada, Las Vegas (UNLV) Development of Communications Director Lori Bachand, Navarro will cover EMG and UNLV’s collaborative development of a profitable variable data publication (VDP) solution